{"id":448,"date":"2019-05-08T15:56:06","date_gmt":"2019-05-08T13:56:06","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=448"},"modified":"2024-04-11T08:15:52","modified_gmt":"2024-04-11T06:15:52","slug":"molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/","title":{"rendered":"Molecular Mechanisms and Experimental Therapy in Oncology Program – Oncobell"},"content":{"rendered":"\n

\n\t\tMolecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell)\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\t

The research carried out by the different groups in the program covers most of the research stages, from basic research to clinical application. Improving the patient’s prognosis is a common objective that is targeted either from the study at the molecular level and signaling pathways, or through the definition of unresolved clinical needs for each disease. The interaction between these two approaches gives rise to better ideas and speeds up the process of transfer from the laboratory to the clinic. The organization of the program also seeks to expand the network of contacts both internally and externally to optimize fundraising capabilities and the scientific impact of IDIBELL’s research.<\/p>\n\t\t\t\t\"white-blood-cell-cell-blood-cell-blood-45239\"\n\t

Oncobell brings together research teams to fight cancer in a multidisciplinary manner<\/p>\n

21<\/h2>\n

Groups<\/h2>\n

94<\/h2>\n

Principal investigators<\/h2>\n

\n\t\tResearch Groups\n\t<\/h3>\n\t\t\t\t\n\t\t\t\t\"colorectal_adenocarcinoma_cytology_intermed_mag-e1587739500516\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tMoreno & Salazar Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tColorectal Cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"108-mortcelular-cmunozpinedo-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tMu\u00f1oz-Pinedo & Nadal Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tPreclinical and experimental research in thoracic tumors (PReTT)\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"neuroblastoma_rosettes\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGil Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tApoptosis and Cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"110-tgfbetacancer-fabregat-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tFabregat Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tTGF-beta and cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"all_-_peripherial_blood_-_diagnosis_-_01\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tSureda Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tHematopoyetic and lymphoid tumors\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"112-sarcoma-omteztirado-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tMart\u00ednez-Tirado Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tSarcoma\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"113-radiobiologiacancer-guedea-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGuedea Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tRadiobiology & Cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"114-cancerhereditari-capella-2def_2\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tCapell\u00e1 & L\u00e1zaro Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tHereditary cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"metabolism-and-cancer3s\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tThomas Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tMetabolism and Cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"511-malaltiescapcoll-mmanos-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tMa\u00f1os Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tHead and neck diseases\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"119-neurooncologia-jbruna-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tBruna Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tNeuro-Oncology\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"mucinous_lmp_ovarian_tumour_intermed_mag\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tMatias-Guiu Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tGynaecological Cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"envejecimiento-y-cancer\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tMu\u00f1oz Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tAgeing and Cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"Immunity-inflammation-and-cancer2\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tSoler Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tImmunity, inflammation and cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"transformacion-y-metastasi\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGonz\u00e1lez-Su\u00e1rez Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tTransformation and Metastasis\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\"Purificacion-Mu\u00f1oz\"\n

\n\t\tMu\u00f1oz Moruno, Purificaci\u00f3n\n\t<\/h4>\n

\n\t\tPROGRAM CO-COORDINATOR\n\t<\/h4>\n

\n\t\t\n\t\tp.munoz@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Josep-Maria-Piulats-Rodriguez\"\n

\n\t\tPiulats Rodriguez, Jose Maria\n\t<\/h4>\n

\n\t\tPROGRAM CO-COORDINATOR\n\t<\/h4>\n

\n\t\t\n\t\tjpiulats@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tAytes Meneses, Alvaro\n\t<\/h4>\n

\n\t\tTEACHING CO-COORDINATOR\n\t<\/h4>\n

\n\t\t\n\t\taaytes@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tRodriguez Barrueco, Ruth\n\t<\/h4>\n

\n\t\tTEACHING CO-COORDINATOR\n\t<\/h4>\n

\n\t\t\n\t\trrodriguezb@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tProCURE groups\n\t<\/h3>\n\t\t\t\t\n\t\t\t\t\"angiogenesis-tumoral\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tCasanovas Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tTumour Angiogenesis\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"viroterapia-del-cancer\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tAlemany & Piulats Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tCancer Immunotherapy\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"quimioresistencia-y-xenografts-ortotopicos\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGarcia & Villanueva Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tTumor and stromal chemoresistance\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"cancer-de-mama\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tPujana Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tBreast cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"mecanismos-de-resistencia-y-progresion-en-el-cancer-de-prostata\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tAytes Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tResistance and Progression Mechanisms in Prostate Cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"senializacion-molecular\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tVi\u00f1als Group\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tMolecular signaling in Cancer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\"Miguel-Angel-Pujana\"\n

\n\t\tGenestar Pujana, Miguel \u00c1ngel\n\t<\/h4>\n

\n\t\tProCURE COORDINATOR\n\t<\/h4>\n

\n\t\t\n\t\tmgenestar@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tRelated news\n\t<\/h3>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tA new tool based on Artificial Intelligence will improve brain tumour diagnosis<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/03\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tThe Spanish Association Against Cancer in Barcelona finances two IDIBELL projects with 445,000 euros<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t07\/03\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tThe first Innovation Conference on the Diagnosis and Treatment of Lung Cancer Patients at Bellvitge Campus takes place<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t16\/02\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tAn anticancer drug opens a new path for the treatment of Parkinson’s<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/02\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tAlterations in the blood immune system found to increase cancer risk<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t06\/02\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tScientists present an oncolytic virus targeting NK cells with great antitumor potential<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/01\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tScientists find a new mechanism that explains the development of vascular malformations<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t11\/01\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tScientists find how to define targeted therapies in lung cancer thanks to a genetic sequencing platform<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t04\/01\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tArtificial intelligence helps take decisions about bone marrow transplant<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t21\/12\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tScientists open up a new way to fight cancer through the MYC gene<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t19\/12\/2023\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"

Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell) Summary The research carried out by the different groups in the program covers most of the research stages, from basic research to clinical application. Improving the patient’s prognosis is a common objective that is targeted either from the study at the molecular level and signaling pathways, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":446,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-08 13:01:56","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/448"}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=448"}],"version-history":[{"count":6,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/448\/revisions"}],"predecessor-version":[{"id":23900,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/448\/revisions\/23900"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/446"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}